Ascendis Pharma A/S (BVMF:A1SN34)

Ascendis Pharma Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	75,820	72,093	50,925	34,572	36,074	42,542
Market Cap Growth	38.30%	41.57%	47.30%	-4.17%	-15.20%	-9.05%
Enterprise Value	77,344	73,867	52,050	35,652	34,094	37,197
Last Close Price	76.05	77.00	56.82	41.20	39.78	-
PS Ratio	16.28	15.48	21.87	24.17	124.77	863.17
PB Ratio	-72.01	-68.47	-75.24	-44.24	24.25	7.60
P/TBV Ratio	-	-	-	-	24.70	7.64
P/FCF Ratio	258.17	245.48	-	-	-	-
P/OCF Ratio	217.53	206.83	-	-	-	-
EV/Sales Ratio	18.02	15.86	22.35	24.92	117.92	754.73
EV/FCF Ratio	263.36	251.52	-	-	-	-
Debt / Equity Ratio	-5.35	-5.35	-8.10	-4.42	1.93	0.12
Debt / FCF Ratio	19.20	19.20	-	-	-	-
Net Debt / Equity Ratio	-1.57	-1.57	-2.81	-1.68	-0.89	-0.77
Net Debt / EBITDA Ratio	-1.95	-1.95	-1.08	-0.56	0.43	1.57
Net Debt / FCF Ratio	5.63	5.63	-0.97	-0.52	0.46	1.55
Asset Turnover	0.58	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.32	0.32	0.18	0.26	0.12	-
Quick Ratio	0.72	0.72	0.81	0.62	1.06	7.03
Current Ratio	1.04	1.04	1.17	0.95	1.29	8.03
Return on Equity (ROE)	-	-	-	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	-6.86%	-6.86%	-17.38%	-29.73%	-32.29%	-27.35%
Return on Capital Employed (ROCE)	-58.40%	-58.40%	-102.60%	-511.40%	-150.60%	-45.90%
Earnings Yield	-1.95%	-2.05%	-4.75%	-7.47%	-9.13%	-5.71%
FCF Yield	0.39%	0.41%	-3.87%	-7.29%	-7.99%	-6.57%
Buyback Yield / Dilution	-4.69%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.